TD Private Client Wealth LLC

SEC CIK: 0001551017
Latest filing: Aug 4, 2026

SEC filings (opens in a new tab)

SNDX holding history

Syndax Pharmaceuticals Inc in every 13F filed by TD Private Client Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SNDX overview All 13F holders of SNDX Full Q2 2026 holdings

Shares (Q2 2026): 37
Value: $809
% of portfolio: <0.1%
Quarters held: 2; Since Q2 2025

Holdings of SNDX by TD Private Client Wealth LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	37	$809	<0.1%	+37	New	Holders
Q3 2025	0	$0	0.0%	−54−100.0%	Sold out	Holders
Q2 2025	54	$506	<0.1%	+54	New	Holders